Related Experiment Videos
Metallothionein expression in human prostate gland
Ziad M Bataineh1, Mohamad K Nusier
1Department of Anatomy, Jordan University of Science and Technology, School of Medicine, Irbid, Jordan. ziad@just.edu.jo
Saudi Medical Journal
|December 4, 2003
Summary
Metallothionein (MT) distribution differs in prostate tissues. In benign prostatic hypertrophy, MT is found in cell nuclei, but in adenocarcinoma, it is in the cytoplasm, aiding diagnosis.
Area of Science:
- Urology
- Oncology
- Cell Biology
Background:
- Metallothionein (MT) is a protein involved in cellular defense.
- Understanding MT distribution in prostate conditions is crucial for diagnosis.
Purpose of the Study:
- To detect and compare metallothionein (MT) distribution in prostate epithelial cells.
- To investigate MT localization in benign prostatic hypertrophy (BPH) versus prostate adenocarcinoma.
Main Methods:
- Immunocytochemistry using a primary antibody against MT.
- Indirect peroxidase antiperoxidase procedure on prostate tissue samples.
Main Results:
- All prostate tissues examined showed positive metallothionein (MT) reactions.
- MT localized primarily in epithelial cell nuclei in BPH.
- MT localized primarily in epithelial cell cytoplasm in adenocarcinoma.
Conclusions:
- Metallothionein (MT) expression patterns vary with prostate pathological status.
- MT distribution differences may assist in diagnosing and evaluating prostate conditions.